Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2013

Open Access 01-12-2013 | Original research article

Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease

Authors: Michela Bellocchia, Monica Masoero, Antonio Ciuffreda, Silvia Croce, Arianna Vaudano, Roberto Torchio, Monica Boita, Caterina Bucca

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2013

Login to get access

Abstract

Background

Cardiovascular disease (CVD) is a common comorbidity in patients with chronic airway obstruction, and is associated with systemic inflammation and airway obstruction. The aim of this study was to evaluate the predictors of CVD in two different conditions causing chronic airway obstruction, asthma and COPD.

Methods

Lung function tests, clinical and echocardiographic data were assessed in 229 consecutive patients, 100 with asthma and 129 with COPD. CVD was classified into: pressure overload (PO) and volume overload (VO). Sub-analysis of patients with ischemic heart disease (IHD) and pulmonary hypertension (PH) was also performed.

Results

CVD was found in 185 patients (81%: 51% COPD and 30% asthmatics) and consisted of PO in 42% and of VO in 38% patients. COPD patients, as compared to asthmatics, had older age, more severe airway obstruction, higher prevalence of males, of smokers, and of CVD (91% vs 68%), either PO (46% vs 38%) or VO (45% vs 30%). CVD was associated with older age and more severe airway obstruction both in asthma and COPD. In the overall patients the predictive factors of CVD were age, COPD, and male sex; those of PO were COPD, BMI, VC, FEV1 and MEF50 and those of VO were age, VC and MEF50. In asthma, the predictors of CVD were VC, FEV1, FEV1 /VC%, and PaO2, those of PO were VC, FEV1 and FEV1 /VC%, while for VO there was no predictor. In COPD the predictors of CVD were age, GOLD class and sex, those of VO age, VC and MEF50, and that of PO was BMI. Sub-analysis showed that IHD was predicted by COPD, age, BMI and FEV1, while PH (found only in 25 COPD patients), was predicted by VO (present in 80% of the patients) and FEV1. In subjects aged 65 years or more the prevalence of CVD, PO and VO was similar in asthmatic and COPD patients, but COPD patients had higher prevalence of males, smokers, IHD, PH, lower FEV1 and higher CRP.

Conclusions

The results of this study indicate that cardiovascular diseases are frequent in patients with chronic obstructive disorders, particularly in COPD patients. The strongest predictors of CVD are age and airway obstruction. COPD patients have higher prevalence of ischemic heart disease and pulmonary hypertension. In the elderly the prevalence of PO and VO in asthma and COPD patients is similar.
Appendix
Available only for authorised users
Literature
2.
go back to reference The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2013. http://www.goldcopd.org The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2013. http://​www.​goldcopd.​org
3.
go back to reference Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28: 523-532. 10.1183/09031936.06.00124605.CrossRefPubMed Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28: 523-532. 10.1183/09031936.06.00124605.CrossRefPubMed
4.
go back to reference Sin DD, Wu L, Man SF: The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005, 127: 1952-1959. 10.1378/chest.127.6.1952.CrossRefPubMed Sin DD, Wu L, Man SF: The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005, 127: 1952-1959. 10.1378/chest.127.6.1952.CrossRefPubMed
5.
go back to reference Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG: The Neutrophilic Inflammatory Phenotype Is Associated With Systemic Inflammation in Asthma. Chest. 2012, 142: 86-93. 10.1378/chest.11-1838.CrossRefPubMed Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG: The Neutrophilic Inflammatory Phenotype Is Associated With Systemic Inflammation in Asthma. Chest. 2012, 142: 86-93. 10.1378/chest.11-1838.CrossRefPubMed
6.
go back to reference Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR: C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006, 61: 23-28.PubMedCentralCrossRefPubMed Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR: C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006, 61: 23-28.PubMedCentralCrossRefPubMed
7.
go back to reference Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF: Systemic effects of smoking. Chest. 2007, 131: 1557-1566. 10.1378/chest.06-2179.CrossRefPubMed Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF: Systemic effects of smoking. Chest. 2007, 131: 1557-1566. 10.1378/chest.06-2179.CrossRefPubMed
8.
go back to reference Friedman GD, Klatsky AL, Siegelaub AB: Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1976, 294: 1071-1075. 10.1056/NEJM197605132942001.CrossRefPubMed Friedman GD, Klatsky AL, Siegelaub AB: Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1976, 294: 1071-1075. 10.1056/NEJM197605132942001.CrossRefPubMed
9.
go back to reference Ebi-Kryston KL, Hawthorne VM, Rose G, Shipley MJ, Gillis CR, Hole DJ, Carmen W, Eshleman S, Higgins MW: Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol. 1989, 18: 84-88. 10.1093/ije/18.1.84.CrossRefPubMed Ebi-Kryston KL, Hawthorne VM, Rose G, Shipley MJ, Gillis CR, Hole DJ, Carmen W, Eshleman S, Higgins MW: Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol. 1989, 18: 84-88. 10.1093/ije/18.1.84.CrossRefPubMed
10.
go back to reference Ebi-Kryston KL: Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol. 1988, 41: 251-260. 10.1016/0895-4356(88)90129-1.CrossRefPubMed Ebi-Kryston KL: Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol. 1988, 41: 251-260. 10.1016/0895-4356(88)90129-1.CrossRefPubMed
11.
go back to reference Gulsvik A, Hansteen V, Sivertssen E: Cardiac arrhythmias in patients with serious pulmonary diseases. Scand J Respir Dis. 1978, 59: 154-159.PubMed Gulsvik A, Hansteen V, Sivertssen E: Cardiac arrhythmias in patients with serious pulmonary diseases. Scand J Respir Dis. 1978, 59: 154-159.PubMed
12.
go back to reference Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, Davey Smith G, Upton M, Hawthorne V, Sin DD, Man SF, Van Eeden S, Mapel DW, Vestbo J: The natural history of chronic obstructive pulmonary disease. Eur Respir J. 2006, 27: 627-643. 10.1183/09031936.06.00024605.CrossRefPubMed Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, Davey Smith G, Upton M, Hawthorne V, Sin DD, Man SF, Van Eeden S, Mapel DW, Vestbo J: The natural history of chronic obstructive pulmonary disease. Eur Respir J. 2006, 27: 627-643. 10.1183/09031936.06.00024605.CrossRefPubMed
13.
go back to reference Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM: Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996, 313: 711-715. 10.1136/bmj.313.7059.711.PubMedCentralCrossRefPubMed Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM: Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996, 313: 711-715. 10.1136/bmj.313.7059.711.PubMedCentralCrossRefPubMed
14.
go back to reference Cazzola M, Puxeddu E, Bettoncelli G, Novelli L, Segreti A, Cricelli C, Calzetta L: The prevalence of asthma and COPD in Italy: a practice-based study. Respir Med. 2011, 105: 386-391. 10.1016/j.rmed.2010.09.022.CrossRefPubMed Cazzola M, Puxeddu E, Bettoncelli G, Novelli L, Segreti A, Cricelli C, Calzetta L: The prevalence of asthma and COPD in Italy: a practice-based study. Respir Med. 2011, 105: 386-391. 10.1016/j.rmed.2010.09.022.CrossRefPubMed
15.
go back to reference Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998, 158: 1855-1867. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998, 158: 1855-1867.
16.
go back to reference Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009, 119: 1977-2016.CrossRefPubMed Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009, 119: 1977-2016.CrossRefPubMed
17.
go back to reference Quanjer PhH (ed.): Standardized lung function testing. Report Working Party Standardization of Lung Function Tests. European Community for Coal and Steel. Bull Eur Physiopathol Respir. 1983, 19 (Suppl. 5): 1-95. Quanjer PhH (ed.): Standardized lung function testing. Report Working Party Standardization of Lung Function Tests. European Community for Coal and Steel. Bull Eur Physiopathol Respir. 1983, 19 (Suppl. 5): 1-95.
18.
go back to reference Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J: Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011, 123 (suppl 4): e18-e209.PubMedCentralCrossRefPubMed Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J: Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011, 123 (suppl 4): e18-e209.PubMedCentralCrossRefPubMed
19.
go back to reference Mannino DM, Thorn D, Swensen A, Holguin F: Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008, 32: 962-969. 10.1183/09031936.00012408.CrossRefPubMed Mannino DM, Thorn D, Swensen A, Holguin F: Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008, 32: 962-969. 10.1183/09031936.00012408.CrossRefPubMed
20.
go back to reference Schanen JG, Iribarren C, Shahar E, Punjabi NM, Rich SS, Sorlie PD, Folsom AR: Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax. 2005, 60: 633-638. 10.1136/thx.2004.026484.PubMedCentralCrossRefPubMed Schanen JG, Iribarren C, Shahar E, Punjabi NM, Rich SS, Sorlie PD, Folsom AR: Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax. 2005, 60: 633-638. 10.1136/thx.2004.026484.PubMedCentralCrossRefPubMed
21.
go back to reference Onufrak SJ, Abramson JL, Austin HD, Holguin F, McClellan WM, Vaccarino LV: Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol. 2008, 101: 1247-1252. 10.1016/j.amjcard.2007.12.024.PubMedCentralCrossRefPubMed Onufrak SJ, Abramson JL, Austin HD, Holguin F, McClellan WM, Vaccarino LV: Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol. 2008, 101: 1247-1252. 10.1016/j.amjcard.2007.12.024.PubMedCentralCrossRefPubMed
22.
go back to reference Iribarren C, Tolstykh IV, Miller MK, Sobel E, Eisner MD: Adult Asthma and Risk of Coronary Heart Disease, Cerebrovascular Disease, and Heart Failure: A Prospective Study of 2 Matched Cohorts. Am J Epidemiol. 2012, 176: 1014-1024. 10.1093/aje/kws181.CrossRefPubMed Iribarren C, Tolstykh IV, Miller MK, Sobel E, Eisner MD: Adult Asthma and Risk of Coronary Heart Disease, Cerebrovascular Disease, and Heart Failure: A Prospective Study of 2 Matched Cohorts. Am J Epidemiol. 2012, 176: 1014-1024. 10.1093/aje/kws181.CrossRefPubMed
23.
go back to reference de Lucas-Ramos P, Izquierdo-Alonso JL, Rodriguez-Gonzalez Moro JM, Frances JF, Lozano PV, Bellón-Cano JM: Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Int J Chron Obstruct Pulmon Dis. 2012, 7: 679-686.PubMedCentralPubMed de Lucas-Ramos P, Izquierdo-Alonso JL, Rodriguez-Gonzalez Moro JM, Frances JF, Lozano PV, Bellón-Cano JM: Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Int J Chron Obstruct Pulmon Dis. 2012, 7: 679-686.PubMedCentralPubMed
24.
go back to reference Stone IS, Barnes NC, Petersen SE: Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?. Heart. 2012, 98: 1055-1062. 10.1136/heartjnl-2012-301759.CrossRefPubMed Stone IS, Barnes NC, Petersen SE: Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?. Heart. 2012, 98: 1055-1062. 10.1136/heartjnl-2012-301759.CrossRefPubMed
Metadata
Title
Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease
Authors
Michela Bellocchia
Monica Masoero
Antonio Ciuffreda
Silvia Croce
Arianna Vaudano
Roberto Torchio
Monica Boita
Caterina Bucca
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2013
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/2049-6958-8-58

Other articles of this Issue 1/2013

Multidisciplinary Respiratory Medicine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine